Gilead Sciences, Inc. has announced that the European Commission has on 18 November 2013, granted marketing authorization for Vitekta (elvitegravir...
On 19 September 2013, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting...